Your browser doesn't support javascript.
loading
HIV-1 drug resistance in adults and adolescents on protease inhibitor-based antiretroviral therapy in KwaZulu-Natal Province, South Africa.
Chimukangara, Benjamin; Lessells, Richard J; Sartorius, Benn; Gounder, Lilishia; Manyana, Sontaga; Pillay, Melendhran; Singh, Lavanya; Giandhari, Jennifer; Govender, Kerusha; Samuel, Reshmi; Msomi, Nokukhanya; Naidoo, Kogieleum; de Oliveira, Tulio; Moodley, Pravi; Parboosing, Raveen.
Afiliação
  • Chimukangara B; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD,
  • Lessells RJ; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Sartorius B; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Gounder L; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
  • Manyana S; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
  • Pillay M; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
  • Singh L; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Govender K; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
  • Samuel R; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
  • Msomi N; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
  • Naidoo K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; South African Medical Research Council (SAMRC), CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
  • de Oliveira T; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; Department of Global Health, Unive
  • Moodley P; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
  • Parboosing R; Department of Virology, University of KwaZulu-Natal/National Health Laboratory Service, Durban, South Africa.
J Glob Antimicrob Resist ; 29: 468-475, 2022 06.
Article em En | MEDLINE | ID: mdl-34785393

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article